Kakamigahara, Japan

Yasuhiro Zaima

This inventor holds 4 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2018-2021.

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Gifu, JP (2018)
  • Kakamigahara, JP (2019 - 2021)

Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Yasuhiro Zaima: Innovator in Sleep Disorder Treatments

Introduction

Yasuhiro Zaima is a notable inventor based in Kakamigahara, Japan. He has made significant contributions to the field of sleep disorder treatments, holding a total of 4 patents. His work focuses on developing compositions and methods that target insomnia and related conditions.

Latest Patents

Zaima's latest patents include innovative compounds that act as potent orexin receptor antagonists. One such compound, (1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl) cyclopropanecarboxamide, has shown promise in treating sleep disorders like insomnia. These inventions may also have therapeutic applications beyond sleep disorders.

Career Highlights

Yasuhiro Zaima is currently associated with Eisai R&D Management Co., Ltd. His work at this company has allowed him to focus on research and development in the pharmaceutical sector, particularly in the area of sleep medicine.

Collaborations

Zaima has collaborated with several professionals in his field, including Margaret Moline and Gina Pastino. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Yasuhiro Zaima is a prominent figure in the innovation of treatments for sleep disorders. His contributions through patents and collaborations highlight his commitment to improving therapeutic options for individuals suffering from insomnia.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…